Seqens Seqens

X

Find Radio Compass News for Propafenone Hydrochloride

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
36
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 225MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 225MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 325MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 425MG

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214184

FDA
21 Apr 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212744

FDA
30 Jun 2020

https://www.upsher-smith.com/news/upsher-smith-launches-propafenone-hydrochloride-extended-release-capsules/

PRESS RELEASE
30 Jun 2020

https://www.prnewswire.com/news-releases/upsher-smith-launches-propafenone-hydrochloride-extended-release-capsules-301086220.html

PRNEWSWIRE
30 Jun 2020

https://www.biospectrumasia.com/news/33/12988/vitruvias-sinotherapeutics-launch-approved-version-of-propafenone-er-in-the-u-s-.html

BIOSPECTRUMASIA
11 Mar 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210339

FDA
07 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205956

FDA
05 Jul 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2017-1505277974.pdf

FDA
13 Sep 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205268

FDA
13 Sep 2017

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-approval-for-rythmol-sr-generic/articleshow/60459858.cms

ECONOMIC TIMES
11 Sep 2017

http://www.prnewswire.com/news-releases/mylan-launches-generic-rythmol-sustained-release-capsules-300278388.html

PR NEWSWIRE
02 Jun 2016

https://www.pharmacompass.com/pdf/news/orion-corp-orions-generic-propafenone-hcl-approved-in-us-as-antiarrhythmic-drug-1463220310.pdf

FDA
11 May 2016

https://www.pharmacompass.com/pdf/news/mylan-pharms-incs-generic-propafenone-hydrochloride-approved-in-us-1462507896.pdf

FDA
29 Apr 2016
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY